Alpha Tau Medical Ltd. (DRTS) - Cash per Single Share

Alpha Tau Medical Ltd. (DRTS) develops targeted alpha-radiation systems to combat tumors, as illustrated by the cash per share structure on the base chart at GURU.Markets. The company achieves cost optimization through the outsourcing of production and testing, while the 1.12 parameter determines the liquidity metric. Expected catalysts for geographic growth are still forming, while current R&D expenses are already priced in by the market.
Comprehensive metric breakdowns and analytics for alphatau.com (DRTS)

This metric determines the share of liquid assets per common share, allowing for an assessment of internal solvency reserves and the risk of inefficient capital utilization. By analyzing the cash balance per share, an investor can see the financial reserve of Alpha Tau Medical Ltd. (DRTS) for the development of precision alpha therapy and the optimization of complex "last mile" isotope logistics to maintain high margins.